Emergence of irreversible modulation in drug discovery

  • 09:00, 16 Oct 24 - 17:30, 17 Oct 24
  • Astrazeneca UK Ltd, Cambridge
  • Print page

Irreversible covalent modulation is a crucial part of the drug discovery toolbox and is an important strategy for finding tractable equity against less druggable targets. However, understanding the binding kinetics, mechanistic PK/PD relationship and SAR of compounds is critical to success as is employing best practice in hit identification and lead optimisation.

Join us in Cambridge on 16-17 October 2024, where we will bring together established leaders and emerging investigators exploring the use of irreversible covalent modulators in drug discovery. Targeting of both cysteine and other amino acid residues will be considered as well as in-depth analysis of the kinetics of irreversible inhibition. Irreversible modulation as a strategy for targeted protein degradation and the identification of covalent chemical equity through proteomic approaches will also be covered.

Learning outcomes:

1) Build a network amongst researchers interested in irreversible modulation in drug discovery
2) Establish the framework for understanding kinetics in drug discovery for irreversible binders
3) Enable researchers to better understand and optimise chemical tools, leads and drug candidates

Session recordings will also be made available to registrants.

Early Bird Affiliate and Retired Non Member Ticket

Early Bird Full and Retired Member Ticket

Early Bird Journal Author, Fellow, Retired Fellow, Honorary Fellow Member Ticket

Early Bird Undergraduate, Postgraduate, Affiliate, ECR and Diploma Student Member Registration

Early Bird Undergraduate, Postgraduate, ECR and Diploma Student Non-Member Registration